Resultados de la búsqueda 361-370 of 4267 for Relapse
... Relapsed/Refractory Multiple Myeloma (RRMM). A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic ...
Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma. Rochester, Minn ...
... relapse, and subsequent therapy. Turkey Tail Mushrooms for women with ER+/HER2- Breast Cancer. Scottsdale/Phoenix, Ariz. The purpose of this study is to ...
Ensayos clínicos · A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia ( ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. A Study ...
... Relapsed/Refractory Multiple Myeloma (RRMM). A Study of the Possible Use of a New Imaging Method with Glioma Tumors. Rochester, Minn. The purpose of this ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?